Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases

被引：0
|
作者：
Palmedo, Holger [1 ]
Guhlke, Stefan [1 ]
Bender, Hans [1 ]
Sartor, Johannes [1 ]
Schoeneich, Georg [2 ]
Risse, Jörn [1 ]
Grünwald, Frank [1 ]
Knapp Jr., F.F. [3 ]
Biersack, Hans-Jürgen [1 ]
机构：
[1] Department of Nuclear Medicine, University of Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany
[2] Department of Urology, University of Bonn, Germany
[3] Nuclear Medicine Group, Oak Ridge National Laboratory, (ORNL), Oak Ridge, TN, United States
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2000年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Grading
引用
收藏
页码：123 / 130
相关论文
共 50 条
  • [21] Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
    Zhang, H
    Tian, M
    Tanada, S
    Endo, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 784S - 784S
  • [22] Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer
    Kolesnikov-Gauthier, H
    Carpentier, P
    Depreux, P
    Vennin, P
    Caty, A
    Sulman, C
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (10) : 1689 - 1694
  • [23] Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer
    Liepe, Knut
    Geidel, Hans Heiner
    Bergmann, Ralf
    Haase, Michael
    Runge, Roswitha
    Kotzerke, Joerg
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (09) : 693 - 699
  • [24] Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study
    Aggarwal, Aarti
    Kaur, Gurjeet
    Jassal, Ravjit Singh
    Medhi, Bikash
    Mittal, Bhagwant Rai
    Shukla, Jaya
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (03) : 188 - 195
  • [25] Radiation dose estimates of Re-186-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: An animal model study
    VanAswegen, A
    Roodt, A
    Marais, J
    Botha, JM
    Naude, H
    Lotter, MG
    Goedhals, L
    Doman, MJ
    Otto, AC
    NUCLEAR MEDICINE COMMUNICATIONS, 1997, 18 (06) : 582 - 588
  • [26] Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
    Liepe, K
    Kropp, J
    Runge, R
    Kotzerke, J
    BRITISH JOURNAL OF CANCER, 2003, 89 (04) : 625 - 629
  • [27] Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
    K Liepe
    J Kropp
    R Runge
    J Kotzerke
    British Journal of Cancer, 2003, 89 : 625 - 629
  • [28] Rhenium-188 as irradiation therapy for non-melanoma skin cancer- Study update
    Schwarzenbock, S.
    Kronert, M.
    Kurth, J.
    Heuschkel, M.
    Ojak, G.
    Roewer, J.
    Troitzsch, P.
    Riedmiller-Schraven, A.
    Doerschner, M.
    Krause, B. J.
    Emmert, S.
    Tietze, J. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S370 - S371
  • [29] RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE [RE-186 HEDP] DOSE-ESCALATION STUDY IN PATIENTS WITH METASTASIZED PROSTATE-CANCER - TARGET ORGAN DOSIMETRY, NARROW TOXICITY AND OPTIMIZED DATA-COLLECTION
    GRAHAM, MC
    LIU, GB
    DAGHIGHIAN, F
    YEH, SDJ
    SCHER, H
    CURLEY, T
    LARSON, SM
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P36 - P37
  • [30] Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study
    Cipriani, Cesidio
    Desantis, Maria
    Dahlhoff, Gerhard
    Brown, Shannon D., III
    Wendler, Thomas
    Olmeda, Mar
    Pietsch, Gunilla
    Eberlein, Bernadette
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 969 - 975
12345